Kiora Pharmaceuticals (KPRX) Receivables (2017 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Receivables came in at $1.8 million in Q1 2026, little changed YoY from $1.8 million in Q1 2025, and up 16.89% on a QoQ basis from $1.5 million in Q4 2025.
Kiora Pharmaceuticals (KPRX) Receivables (2017 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 5 years of Receivables data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Receivables changed 0.05% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (changed 0.05% YoY) and the FY2025 annual result came in at $1.5 million, up 153.29% from the prior year.
- Receivables rose to $1.8 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $2.4 million in Q2 2025 to a low of $189905.0 in Q1 2024.
- A 3-year average of $1.4 million and a median of $1.5 million in 2025 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 837.69% in 2025, down 31.97% in 2025.
- Tracing KPRX's Receivables over 3 years: stood at $601197.0 in 2024, then surged by 153.29% to $1.5 million in 2025, then advanced by 16.89% to $1.8 million in 2026.
- The last three Receivables figures came in at $1.8 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.92 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.57 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.12 Bn | 53.98 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.75 Bn | 28.45 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.72 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.20 Bn | 26.36 Bn | - | - |
| 10 | Kiora Pharmaceuticals | 16.06 Mn | 16.06 Mn | - | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 2.42 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 601,197.00 |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 189,905.00 |
| Mar 31, 2018 | 1.84 Mn |
| Dec 31, 2017 | -485,719.00 |